Groundbreaking Study Reveals Genetic Roots of Addiction Across Drugs

A large-scale genetic study has uncovered key factors behind addiction vulnerability. Researchers analysed data from over 2.2 million people to identify how genes influence substance use disorders. The findings point to a shared biological pathway that drives risk across multiple drugs.

The study, led by Holly Poore at Rutgers University, examined genetic links to alcohol, tobacco, cannabis, and opioid use. Published in Nature Mental Health, it revealed a 'broad externalizing pathway' as the main driver of addiction. This pathway affects how the brain processes rewards, controls impulses, and assesses consequences.

Hundreds of genetic variants were tied to this broad liability, alongside substance-specific genes. For example, some genes influence alcohol metabolism, while others affect nicotine receptors. The team also developed polygenic scores to predict general addiction risk and drug-specific vulnerabilities.

The research involved an international group of scientists and received funding from multiple institutions. It connects the broad externalizing pathway to traits like ADHD, impulsivity, and risk-taking. These insights could help tailor prevention strategies and treatments based on individual genetic profiles.

The findings highlight the role of shared genetic factors in addiction across different substances. By identifying both broad and substance-specific risks, the study opens avenues for more precise interventions. Future research may build on these results to refine prevention and treatment approaches.